Skip to main content
SpringerLink
Log in

Alpelisib/dapagliflozin

Severe hyperglycaemia and weight loss: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sahakian N, et al. SGLT2 inhibitors as potentially helpful drugs in PI3K inhibitor-induced diabetes: a case report. Clinical Diabetes and Endocrinology 7: No. 1, Dec 2021. Available from: URL: http://doi.org/10.1186/s40842-021-00125-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alpelisib/dapagliflozin. Reactions Weekly 1869, 23 (2021). https://doi.org/10.1007/s40278-021-00888-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00888-y

Search

Navigation